NCT01062269View on ClinicalTrials.gov

A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

February 28, 2010

Study Completion Date

April 30, 2010

Conditions
Healthy
Interventions
DRUG

Cholestyramine

Cholestyramine 4 grams one time dose

DRUG

Cholestyramine

Cholestyramine 12 grams one dose, one day

DRUG

Tang

Tang one dose one day

Trial Locations (1)

40213

L-MARC Research Center, Louisville

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

Provident Clinical Research

OTHER

collaborator

Daiichi Sankyo

INDUSTRY

lead

Louisville Metabolic and Atherosclerosis Research Center

OTHER